surmount trial tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide proves to be more

Last week Novo's study made retatrutide less valuable by showing dual agonist tirzepatide cause 25.5% weight loss

Dosing, timing, and suitability depend on your individual health history, current medications, and clinical circumstances

Losing 20 pounds in a month is a goal thats not recommended due to health concerns

In cases where there is considerable increase in liver size, subcapsular hepatocellular necrosis can be due to the mechanical effects of compression (Parker and Gibson 1995)

The UK SmPCs for semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro), as well as their EMA European Public Assessment Reports (EPARs), document well-characterised GI side effect profiles that include nausea, vomiting, diarrhoea, constipation, and dyspepsia

doi: 10.1001/jama.287.11.1420